A genetic clue to the timing of Alzheimer’s disease
A new study identifies a novel genetic factor that may influence the age at which Alzheimer’s disease begins. Researchers performed a genome-wide linkage analysis in families with early-onset Alzheimer’s from the Long-Life Family Study and found a significant signal at the RBFOX1 gene locus. Variants in RBFOX1 were associated with the age of onset, and this association was validated across nine independent cohorts. Further analysis showed that higher expression of RBFOX1 in blood was linked to an earlier onset of the disease, suggesting the gene could be a new therapeutic target for delaying dementia.
Why it might matter to you:
This research moves beyond the established amyloid and tau pathways to identify a novel genetic regulator of disease timing, a key area of investigation for anyone studying neurodegenerative mechanisms. For a neuroscientist focused on brain-behavior relationships and translational models, understanding modifiable genetic factors like RBFOX1 could inform future research into the biological basis of cognitive resilience and the development of preventative strategies.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
